| Product ID |
Product Name |
CAS# |
Purity |
| Y3118032 |
Sotuletinib hydrochloride |
2222138-31-8 |
98% |
| Y3295648 |
BSJ-04-122 |
2513289-74-0 |
99% |
| Y3286069 |
SLK/STK10-IN-1 |
264210-49-3 |
99% |
| Y3268637 |
KR-39038 |
2770300-35-9 |
95% |
| Y3118058 |
Werner syndrome RecQ helicase-IN-3 |
2869954-98-1 |
98% |
| Y3306874 |
Steppogenin-7,4'-di-O-ß-D-glucoside |
1193750-99-0 |
98% |
| Y3309507 |
(2S,3S)-3-((tert-butoxycarbonyl)amino)oxetane-2-carboxylic acid |
2012574-78-4 |
95% |
| Y3307606 |
N-Acetyldopamine dimer-1 |
315188-82-0 |
98% |
| Y3261587 |
Galectin-8N-IN-1 |
2667628-25-1 |
98% |
| Y3255236 |
SPAA-52 |
2837000-75-4 |
98% |
| Y3292527 |
NDB |
1660153-08-1 |
98% |
| Y3118055 |
4-Chloro-3-fluoro-5-(trifluoromethyl)benzoic acid |
1805457-54-8 |
95% |
| Y3118044 |
2-Iodo-3,5-dimethylphenol |
24242-79-3 |
98% |
| Y3268638 |
GCN2-IN-7 |
2396465-33-9 |
99% |
| Y3296687 |
Z4P |
2361760-87-2 |
99% |
| Y3261442 |
FEN1-IN-2 |
824983-94-0 |
99.92% |
| Y3118063 |
2-Bromo-5-(2-methoxyethoxy)pyrazine |
1351523-79-9 |
98% |
| Y3310513 |
Histatin-3 |
112844-49-2 |
99% |
| Y3118056 |
hCAII-IN-8 |
952306-80-8 |
98% |
| Y3307271 |
5-O-Primeverosylapigenin |
2382681-38-9 |
95% |
| Y3294065 |
Velagliflozin proline |
1539295-26-5 |
99% |
| Y3286163 |
Spermine(N3BBB) |
1190203-80-5 |
98% |
| Y3267931 |
Py-MAA-Val-Cit-PAB-MMAE |
2247398-68-9 |
99% |
| Y3308601 |
7-Methoxy obtusifolin |
1820806-09-4 |
98% |
| Y3117948 |
3-Chloroisoxazolo[5,4-b]pyridine |
864871-89-6 |
97% |
| Y3118084 |
1,4-Bis(2,6-dimethylpyridin-4-yl)benzene |
851868-26-3 |
98% |
| Y3288828 |
Ethyl acetoacetate-d3 |
1565868-21-4 |
98% |
| Y3308642 |
Bis(2-methoxy-5-((Z)-3,4,5-trimethoxystyryl)phenyl) hydrogen phosphate |
735261-22-0 |
99% |
| Y3265794 |
Zilurgisertib |
2173389-57-4 |
99% |
| Y3117945 |
(1H-pyrrolo[3,2-b]pyridin-5-yl)methanamine hydrochloride |
1432754-34-1 |
95% |
| Y3293422 |
Pomalidomide-C6-O-C5-O-C4-COOH |
2375774-54-0 |
98% |
| Y3267578 |
(Rac)-Clopidogrel-d3 sulfate |
2468372-74-7 |
95% |
| Y3293215 |
TAT-HA2 Fusion Peptide |
923954-79-4 |
99% |
| Y3118095 |
2-(4,5-Difluoro-2-nitrophenyl)acetonitrile |
425430-84-8 |
95% |
| Y3291329 |
Culmerciclib |
2004705-28-4 |
98% |
| Y3289931 |
SN-38-CO-DMEDA TFA |
1224601-17-5 |
98% |
| Y3118064 |
1,1'-(1H-imidazole-1,3(2H)-diyl)bis(ethan-1-one) |
10284-52-3 |
90% |
| Y3297659 |
Thalidomide-PEG2-NH2 hydrochloride |
2891597-17-2 |
95% |
| Y3290637 |
JNJ-1013 |
2597343-08-1 |
99% |
| Y3267227 |
Glucocorticoid receptor modulator 1 |
2868357-11-1 |
99.79% |
| Y3294857 |
ARN 077 enantiomer |
1439366-88-7 |
99% |
| Y3290518 |
Aldometanib |
2904601-67-6 |
99% |
| Y3118074 |
Tert-butyl (S)-2-ethynyl-2-methylpyrrolidine-1-carboxylate |
2165998-04-7 |
98% |
| Y3268277 |
ULK1-IN-2 |
2497409-01-3 |
99% |
| Y3271657 |
Synstatin 92-119 |
1259384-47-8 |
97% |
| Y3317758 |
TREM2 agonist-2 |
2738485-98-6 |
98% |
| Y3293453 |
IDO2-IN-1 |
2803768-09-2 |
98% |
| Y3292333 |
GPR84 antagonist 1 |
2762180-28-7 |
99% |
| Y3307089 |
Deltasonamide 1 TFA |
2235358-73-1 |
95% |
| Y3287121 |
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal |
2345732-89-8 |
95% |
| Y3294239 |
MMV009085 |
298217-59-1 |
97% |
| Y3271526 |
3-Hydroxychrysene-d11 |
2468771-62-0 |
95% |
| Y3311215 |
Yimitasvir diphosphate |
1959593-63-5 |
98% |
| Y3270054 |
COX-2-IN-6 |
2756347-91-6 |
98% |
| Y3311968 |
N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(1-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)ethylidene)-N2-methyl-L-lysine |
1428229-84-8 |
95% |
| Y3271317 |
MYF-03-176 |
2857937-59-6 |
99.52% |
| Y3286460 |
OF-C4-Deg-Lin |
2383003-60-7 |
95% |
| Y3296337 |
3-(2-(2,6-Dioxopiperidin-3-yl)-3-oxoisoindolin-5-yl)propanoic acid |
2703770-71-0 |
95% |
| Y3287281 |
AS1134900 |
149760-98-5 |
98% |
| Y3271441 |
PqsR/LasR-IN-2 |
2071705-93-4 |
98% |
| Y3267275 |
ML089 |
1306638-12-9 |
99% |
| Y3293905 |
PERK-IN-6 |
1337532-14-5 |
99% |
| Y3293976 |
Resomelagon |
1809420-71-0 |
99% |
| Y3266298 |
SC-VC-PAB-N-Me-L-Ala-Maytansinol |
2226467-76-9 |
98% |
| Y3267213 |
SHR2415 |
2494010-42-1 |
98% |
| Y3269613 |
Gcase activator 2 |
2759897-35-1 |
99% |
| Y3266132 |
SJ995973 |
2882065-25-8 |
98.84% |
| Y3269801 |
Ramelteon-d3 |
1432057-38-9 |
99.0% |
| Y3263708 |
LysoTracker Yellow HCK 123 |
1064123-31-4 |
98.51% |
| Y3271222 |
17ß-HSD1-IN-1 |
2760791-96-4 |
99.34% |
| Y3288481 |
Glucocorticoid receptor agonist-2 Ala-Ala-Mal |
2166376-64-1 |
98% |
| Y3268695 |
tert-Butyl spiro[2.5]octan-6-ylcarbamate |
1256256-52-6 |
95% |
| Y3310094 |
MOG peptide 35-55 |
2022956-48-3 |
98% |
| Y3305140 |
MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan |
2414254-52-5 |
95% |
| Y3259943 |
FITC-hyodeoxycholic acid |
2374144-21-3 |
98% |
| Y3269586 |
2'-Deoxyguanosine-13C10,15N5 |
872624-05-0 |
95% |
| Y3287855 |
P-CAB agent 2 |
1978371-23-1 |
98% |
| Y3270429 |
Vacquinol-1 dihydrochloride |
2309312-85-2 |
99.44% |
| Y3295657 |
TRPV1 antagonist 3 |
2765294-54-8 |
99% |
| Y3307978 |
SARM1-IN-2 |
2396592-52-0 |
98% |
| Y3297086 |
BACE2-IN-1 |
1676107-08-6 |
99% |
| Y3265192 |
Nampt activator-3 |
2790481-63-7 |
99.67% |
| Y3291412 |
Mab Aspartate Decarboxylase-IN-1 |
2755712-12-8 |
99% |
| Y3268254 |
ß-Caryophyllene-d2 |
2006272-96-2 |
94% |
| Y3118047 |
Bis(2,2'-bipyridyl)(4-methyl-4’-carboxypropyl-2,2'-bipyridyl) ruthenium(II) bishexafluorophosphate |
115239-59-3 |
98% |
| Y3307267 |
PI3K-IN-30 |
2281803-22-1 |
98% |
| Y3261016 |
4-(Trifluoromethyl)-2-oxabicyclo[2.1.1]hexane-1-carboxylic acid |
2287318-89-0 |
95% |
| Y3118039 |
1,1'-BIs[(2S,4S)-2,4-bis(1-methylethyl)-1-phosphetanyl]ferrocene |
224057-12-9 |
97% |
| Y3297728 |
TDI-11861 |
2857049-72-8 |
98% |
| Y3288378 |
Certepetide |
2580154-02-3 |
99% |
| Y3306404 |
2-(5-Bromo-2-chlorophenyl)-1,3-dioxolane |
898538-74-4 |
95% |
| Y3255572 |
Xininurad |
2365178-28-3 |
99.59% |
| Y3296162 |
QM295 |
1241046-32-1 |
99% |
| Y3306114 |
ANG1005 |
1075214-55-9 |
98% |
| Y3294655 |
IRAK4-IN-21 |
2170694-04-7 |
99% |
| Y3270911 |
Nitrendipine-d5 |
2469554-26-3 |
99.76% |
| Y3118049 |
Topoisomerase II inhibitor 13 |
451515-89-2 |
98% |
| Y3288330 |
Trametiglue |
2666940-97-0 |
98% |
| Y3296906 |
3-Carboxy-1H-1,2,4-triazole-1-propanoic acid |
2173017-15-5 |
95% |
| Y3304939 |
N-Acetyldopamine dimer-3 |
315188-81-9 |
98% |